ERMA Systems Named to MM+M's 2026 Agency Partners Power List for AI Health Platforms

MIAMI--(BUSINESS WIRE)--ERMA Systems, the AI-powered Medical, Legal, and Regulatory (MLR) review platform built specifically for life sciences organizations, today announced its inclusion on the 2026 Agency Partners Power List published by MM+M, one of the healthcare industry's leading publications.

The recognition highlights organizations shaping the future of healthcare commercialization and innovation. ERMA was recognized in the AI Health Platforms category for its transformative approach to streamlining regulatory review, improving compliance, and accelerating content approvals across pharmaceutical and biotechnology organizations.

"We built ERMA because we saw a significant gap in the market," said Julia Gardner, Founder and CEO of ERMA Systems. "Life sciences teams have been forced to adapt their workflows to rigid legacy systems for years. Our vision was to create an intelligent platform that adapts to how regulatory, medical, and legal teams actually work while leveraging AI to reduce review cycles, improve compliance, and bring therapies to market faster."

Unlike traditional MLR platforms, ERMA combines AI-powered claim identification, automated reference assignment, FDA guidance intelligence, configurable workflows, and audit-ready documentation within a single platform designed to support both emerging biotech and large pharmaceutical organizations.

The recognition follows a year of significant growth for ERMA, including successful pilot programs with pharmaceutical partners and the continued expansion of its AI capabilities. Early results have demonstrated measurable impact, including:

• 62% reduction in overall review time
• 50% fewer review cycles
• 94% claim detection accuracy across promotional materials

ERMA's platform was built to address the growing complexity of healthcare compliance while helping teams prepare for OPDP submissions, promotional review committees, and commercialization activities without the burden of costly legacy software implementations.

"Being recognized by MM+M alongside some of the most innovative companies in healthcare technology is an incredible honor," Gardner added. "This validates our belief that the future of MLR is not simply digitization—it's intelligent, flexible, AI-driven review built around the realities of modern life sciences organizations."

The full MM+M Agency Partners Power List can be viewed on MM+M's website.

About ERMA Systems

ERMA Systems is an AI-powered Medical, Legal, and Regulatory (MLR) review platform designed for pharmaceutical, biotechnology, and life sciences organizations. The platform combines AI-driven claims identification, automated reference assignment, FDA guidance intelligence, configurable workflows, and audit-ready documentation to help teams accelerate content review while maintaining regulatory rigor. ERMA enables organizations to reduce review cycles, improve compliance, and streamline promotional and medical review processes through a modern, flexible approach to MLR.

For more information, visit www.ermasystems.com.